Bhavnani, S. M., Hammel, J. P., Cirincione, B. B., Wikler, M. A., & Ambrose, P. G. (2005). Use of Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Phase 2 and 3 Dosing Strategies for Doripenem. American Society for Microbiology.
Παραπομπή Chicago StyleBhavnani, Sujata M., Jeffrey P. Hammel, Brenda B. Cirincione, Matthew A. Wikler, και Paul G. Ambrose. Use of Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Phase 2 and 3 Dosing Strategies for Doripenem. American Society for Microbiology, 2005.
Παραπομπή MLABhavnani, Sujata M., et al. Use of Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Phase 2 and 3 Dosing Strategies for Doripenem. American Society for Microbiology, 2005.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.